<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK25507" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK25507/" /><meta name="ncbi_pagename" content="Autosomal Dominant Hyper IgE Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Autosomal Dominant Hyper IgE Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Autosomal Dominant Hyper IgE Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2012/06/07" /><meta name="citation_author" content="Amy P Hsu" /><meta name="citation_author" content="Joie Davis" /><meta name="citation_author" content="Jennifer M Puck" /><meta name="citation_author" content="Steven M Holland" /><meta name="citation_author" content="Alexandra F Freeman" /><meta name="citation_pmid" content="20301786" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK25507/" /><meta name="citation_keywords" content="AD-HIES" /><meta name="citation_keywords" content="Job’s Syndrome" /><meta name="citation_keywords" content="STAT3-Deficient Hyper IgE Syndrome" /><meta name="citation_keywords" content="STAT3 Deficiency" /><meta name="citation_keywords" content="AD-HIES" /><meta name="citation_keywords" content="Job's Syndrome" /><meta name="citation_keywords" content="STAT3 Deficiency" /><meta name="citation_keywords" content="STAT3-Deficient Hyper-IgE Syndrome" /><meta name="citation_keywords" content="Signal transducer and activator of transcription 3" /><meta name="citation_keywords" content="STAT3" /><meta name="citation_keywords" content="Autosomal Dominant Hyper IgE Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Autosomal Dominant Hyper IgE Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Amy P Hsu" /><meta name="DC.Contributor" content="Joie Davis" /><meta name="DC.Contributor" content="Jennifer M Puck" /><meta name="DC.Contributor" content="Steven M Holland" /><meta name="DC.Contributor" content="Alexandra F Freeman" /><meta name="DC.Date" content="2012/06/07" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK25507/" /><meta name="description" content="Autosomal dominant hyper IgE syndrome (AD-HIES) is a primary immune deficiency characterized by the classic triad of recurrent skin boils, cyst-forming pneumonias, and extreme elevations of serum IgE. It is now recognized that other common manifestations include eczema, mucocutaneous candidiasis, and several connective tissue and skeletal abnormalities. A rash in the newborn period subsequently evolves into an eczematoid dermatitis. Recurrent staphylococcal skin boils and bacterial pneumonias usually manifest in the first years of life. Pneumatocoeles and bronchiectasis often result from aberrant healing of pneumonias. Mucocutaneous candidiasis is common. A characteristic facial appearance typically emerges in adolescence. Skeletal abnormalities include osteopenia, minimal trauma fractures, and scoliosis. Vascular abnormalities include middle-sized artery tortuosity and aneurysms, with infrequent clinical sequelae of myocardial infarction and subarachnoid hemorrhage. Gastrointestinal (GI) manifestations include gastroesophageal reflux disease; esophageal dysmotility; and rarely colonic perforations, some of which are associated with diverticuli. Fungal infection of the GI tract (typically histoplasmosis, Cryptococcus, and Coccidioides) also occur infrequently. Survival is typically into adulthood, but life span is often shortened. Most deaths are associated with Gram-negative (Pseudomonas) or filamentous fungal pneumonias resulting in hemoptysis. Lymphomas occur at an increased frequency." /><meta name="og:title" content="Autosomal Dominant Hyper IgE Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Autosomal dominant hyper IgE syndrome (AD-HIES) is a primary immune deficiency characterized by the classic triad of recurrent skin boils, cyst-forming pneumonias, and extreme elevations of serum IgE. It is now recognized that other common manifestations include eczema, mucocutaneous candidiasis, and several connective tissue and skeletal abnormalities. A rash in the newborn period subsequently evolves into an eczematoid dermatitis. Recurrent staphylococcal skin boils and bacterial pneumonias usually manifest in the first years of life. Pneumatocoeles and bronchiectasis often result from aberrant healing of pneumonias. Mucocutaneous candidiasis is common. A characteristic facial appearance typically emerges in adolescence. Skeletal abnormalities include osteopenia, minimal trauma fractures, and scoliosis. Vascular abnormalities include middle-sized artery tortuosity and aneurysms, with infrequent clinical sequelae of myocardial infarction and subarachnoid hemorrhage. Gastrointestinal (GI) manifestations include gastroesophageal reflux disease; esophageal dysmotility; and rarely colonic perforations, some of which are associated with diverticuli. Fungal infection of the GI tract (typically histoplasmosis, Cryptococcus, and Coccidioides) also occur infrequently. Survival is typically into adulthood, but life span is often shortened. Most deaths are associated with Gram-negative (Pseudomonas) or filamentous fungal pneumonias resulting in hemoptysis. Lymphomas occur at an increased frequency." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK25507/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/higes/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK25507/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE888CBEDFC897510000000005E602A3.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK25507_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK25507_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/peaf/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/lad-ad/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK25507_"><span class="title" itemprop="name">Autosomal Dominant Hyper IgE Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: AD-HIES, Job&#x02019;s Syndrome, STAT3-Deficient Hyper IgE Syndrome, STAT3 Deficiency</div><p class="contrib-group"><span itemprop="author">Amy P Hsu</span>, BA, <span itemprop="author">Joie Davis</span>, PNP-BC, APNG, <span itemprop="author">Jennifer M Puck</span>, MD, <span itemprop="author">Steven M Holland</span>, MD, and <span itemprop="author">Alexandra F Freeman</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK25507_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK25507_ai__"><div class="contrib half_rhythm"><span itemprop="author">Amy P Hsu</span>, BA<div class="affiliation small">National Institute of Allergy and Infectious Diseases<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.diain@sniwt" class="oemail">vog.hin.diain@sniwt</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Joie Davis</span>, PNP-BC, APNG<div class="affiliation small">National Institute of Allergy and Infectious Diseases<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.diain@sivadj" class="oemail">vog.hin.diain@sivadj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Jennifer M Puck</span>, MD<div class="affiliation small">Professor of Pediatrics, University of California San Francisco<br />San Francisco, California<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.fscu.sdep@jkcup" class="oemail">ude.fscu.sdep@jkcup</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Steven M Holland</span>, MD<div class="affiliation small">Chief, Laboratory of Clinical Infectious Diseases<br />National Institute of Allergy and Infectious Diseases<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.diain@dnallohs" class="oemail">vog.hin.diain@dnallohs</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Alexandra F Freeman</span>, MD<div class="affiliation small">National Institute of Allergy and Infectious Diseases<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.diain@laameerf" class="oemail">vog.hin.diain@laameerf</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 23, 2010</span>; Last Update: <span itemprop="dateModified">June 7, 2012</span>.</p><p><em>Estimated reading time: 20 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="higes.Summary" itemprop="description"><h2 id="_higes_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Autosomal dominant hyper IgE syndrome (AD-HIES) is a primary immune deficiency characterized by the classic triad of recurrent skin boils, cyst-forming pneumonias, and extreme elevations of serum IgE. It is now recognized that other common manifestations include eczema, mucocutaneous candidiasis, and several connective tissue and skeletal abnormalities. A rash in the newborn period subsequently evolves into an eczematoid dermatitis. Recurrent staphylococcal skin boils and bacterial pneumonias usually manifest in the first years of life. Pneumatocoeles and bronchiectasis often result from aberrant healing of pneumonias. Mucocutaneous candidiasis is common. A characteristic facial appearance typically emerges in adolescence. Skeletal abnormalities include osteopenia, minimal trauma fractures, and scoliosis. Vascular abnormalities include middle-sized artery tortuosity and aneurysms, with infrequent clinical sequelae of myocardial infarction and subarachnoid hemorrhage. Gastrointestinal (GI) manifestations include gastroesophageal reflux disease; esophageal dysmotility; and rarely colonic perforations, some of which are associated with diverticuli. Fungal infection of the GI tract (typically histoplasmosis, <i>Cryptococcus,</i> and <i>Coccidioides</i>) also occur infrequently. Survival is typically into adulthood, but life span is often shortened. Most deaths are associated with Gram-negative (<i>Pseudomonas</i>) or filamentous fungal pneumonias resulting in hemoptysis. Lymphomas occur at an increased frequency.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Diagnosis requires a high index of suspicion based on clinical features. A clinical scoring system that includes both immunologic/infectious manifestations and skeletal/connective tissue abnormalities has been developed. Molecular genetic testing of <i>STAT3,</i> the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause AD-HIES, confirms the diagnosis.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> The mainstay of treatment is prevention of staphylococcal abscesses and pneumonias with anti-staphylococcal prophylactic antibiotics as well as early aggressive treatment of infections. Use of antibiotics and antifungal agents depends on the nature of the infection and the extent of involvement. Antiseptic therapies for the skin such as bleach baths are beneficial. Medications such as histamine-1 antagonists to control pruritus are helpful for more significant eczema. Optimization of calcium and vitamin D intake may be considered to improve bone health.</p><p><i>Surveillance:</i> Periodic chest imaging and high clinical suspicion assist in early detection of infections. Culture of skin lesions and sputum samples helps direct therapy. Routine dental care is necessary to ensure timely removal of primary teeth to allow eruption of secondary teeth. Routine screening of adolescents for early signs of scoliosis is recommended.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>AD-HIES is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. To date, the majority of cases have been caused by <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants. Each child of an individual with AD-HIES has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Prenatal diagnosis for pregnancies at increased risk is possible if the pathogenic variant in the family is known.</p></div></div><div id="higes.Diagnosis"><h2 id="_higes_Diagnosis_">Diagnosis</h2><div id="higes.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>Until the 2007 identification of <i>STAT3</i> pathogenic variants as the cause of most cases of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> hyper-IgE syndrome (AD-HIES), diagnosis was primarily made through the long-standing classic triad of recurrent skin boils, cyst-forming pneumonias, and extreme elevations of serum concentration of immunoglobulin E (IgE).</p><p>A clinical scoring system was devised by the NIH group who recognized AD-HIES to be a multisystem disorder [<a class="bk_pop" href="#higes.REF.grimbacher.1999b.735">Grimbacher et al 1999b</a>]. Diagnosis now combines a high index of suspicion based on clinical features (as delineated in the clinical scoring system; see <a class="figpopup" href="/books/NBK25507/table/higes.T.scoring_system_with_clinical_and/?report=objectonly" target="object" rid-figpopup="fighigesTscoringsystemwithclinicaland" rid-ob="figobhigesTscoringsystemwithclinicaland">Table 1</a>) with <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>STAT3</i> [<a class="bk_pop" href="#higes.REF.holland.2007.1608">Holland et al 2007</a>, <a class="bk_pop" href="#higes.REF.minegishi.2007.1058">Minegishi et al 2007</a>]. <a class="bk_pop" href="#higes.REF.woellner.2010.424">Woellner et al [2010]</a> have developed guidelines that include the NIH clinical feature scoring system as well as determination of IL-17-producing T cells.</p><p>Scoring system components include both immunologic/infectious manifestations and skeletal/connective tissue abnormalities. Scores are weighted to reflect the severity of a finding and to emphasize findings that are specific for AD-HIES. In order to have a high likelihood of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with AD-HIES, individuals should have a combination of both immunologic/infectious features and non-immunologic features. In the NIH clinical feature scoring system, a score of:</p><ul><li class="half_rhythm"><div>&#x0003e;40 is suggestive of AD-HIES;</div></li><li class="half_rhythm"><div>20-40 is considered indeterminate;</div></li><li class="half_rhythm"><div>&#x0003c;20 is considered unlikely to indicate AD-HIES.</div></li></ul><div id="higes.T.scoring_system_with_clinical_and" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Scoring System with Clinical and Laboratory Tests for Individuals in Kindreds with HIES</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK25507/table/higes.T.scoring_system_with_clinical_and/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__higes.T.scoring_system_with_clinical_and_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" style="text-align:left;vertical-align:middle;">Clinical Finding</th><th id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" colspan="10" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Points&#x000a0;<sup>1</sup></th></tr><tr><th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">0</th><th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</th><th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</th><th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3</th><th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</th><th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5</th><th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6</th><th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7</th><th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8</th><th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10</th></tr></thead><tbody><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Highest serum-IgE level (IU/mL)&#x000a0;<sup>2</sup></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;200</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">200-500</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">501-1,000</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1,001-2,000</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;2,000</td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Skin abscesses</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1-2</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3-4</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;4</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pneumonia (episodes over lifetime)</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;3</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Parenchymal lung anomalies</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absent</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bronchiectasis</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pneumatocoele</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Retained primary teeth</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;3</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Scoliosis, maximum curvature</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;10&#x000b0;</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10&#x000b0;-14&#x000ba;</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15&#x000b0;-20&#x000b0;</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;20&#x000b0;</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fractures with minor trauma</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1-2</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;2</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Highest eosinophil count (cells/&#x003bc;L)&#x000a0;<sup>3</sup></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;700</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">700-800</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;800</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Characteristic face</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absent</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mildly present</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Present</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Midline anomaly&#x000a0;<sup>4</sup></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absent</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Present</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Newborn rash</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absent</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Present</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Eczema (worst stage)</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absent</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mild</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Moderate</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Upper-respiratory infections per year</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1-2</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4-6</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;6</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Candidiasis</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oral</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fingernails</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Systemic</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Other serious infections</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fatal infection</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absent</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Present</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hyperextensibility</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absent</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Present</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lymphoma</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absent</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Present</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Increased nasal width&#x000a0;<sup>5</sup></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1 SD</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1-2 SD</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;2 SD</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">High palate</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absent</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Present</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Young-age correction</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;5 years</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2-5 years</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1-2 years</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;1 year</td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">From <a class="bk_pop" href="#higes.REF.grimbacher.1999b.735">Grimbacher et al [1999b]</a></p></div></dd><dt>1. </dt><dd><div id="higes.TF.1.1"><p class="no_margin">The entry in the furthest-right column is assigned the maximum points allowed for each finding.</p></div></dd><dt>2. </dt><dd><div id="higes.TF.1.2"><p class="no_margin">Normal &#x0003c;130 IU/mL</p></div></dd><dt>3. </dt><dd><div id="higes.TF.1.3"><p class="no_margin">700/&#x003bc;L = 1 standard deviation (SD), 800/&#x003bc;L = 2 SD above the mean value for normal individuals.</p></div></dd><dt>4. </dt><dd><div id="higes.TF.1.4"><p class="no_margin">For example, cleft palate, cleft tongue, hemivertebrae, other vertebral anomaly (see <a class="bk_pop" href="#higes.REF.grimbacher.1999a.692">Grimbacher et al [1999a]</a>).</p></div></dd><dt>5. </dt><dd><div id="higes.TF.1.5"><p class="no_margin">Compared with age- and sex-matched controls [<a class="bk_pop" href="#higes.REF.farkas.1994">Farkas 1994</a>]</p></div></dd></dl></div></div></div><p><b>Immunologic/infectious features</b> include elevation of serum concentration of IgE, eosinophilia, recurrent skin abscesses (often &#x0201c;cold,&#x0201d; manifesting little inflammatory reaction), pneumonias, destructive parenchymal lung lesions following infection, other serious or fatal infections, newborn rash, eczema, sinusitis or otitis and mucocutaneous candidiasis.</p><p><b>Non-immune features</b> include three or more retained primary teeth, scoliosis, bone fractures following minimal trauma, hyperextensibility of joints, characteristic facial appearance, increased nasal width, high palate, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> skeletal anomalies and lymphoma.</p><p>Not all features need to be present to diagnose AD-HIES, and because features accrue over time, the clinical diagnosis can be uncertain in young children. Moreover, early institution of effective prophylactic antibiotics can attenuate or prevent many of the infectious complications that would otherwise facilitate diagnosis.</p></div><div id="higes.Testing"><h3>Testing</h3><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div>Elevated serum concentration of IgE. Serum IgE (normally &#x0003c;130 IU/mL in adults) is typically above 2000 IU/mL, but can be variable and may decrease in adulthood to normal levels.</div></li><li class="half_rhythm"><div>Eosinophilia &#x0003e;700/&#x003bc;L. Present in the majority of individuals</div></li><li class="half_rhythm"><div>Diminished memory T and B cells</div></li><li class="half_rhythm"><div>Near absence of IL-17 producing Th17 cell differentiation [<a class="bk_pop" href="#higes.REF.ma.2008.1551">Ma et al 2008</a>, <a class="bk_pop" href="#higes.REF.milner.2008.773">Milner et al 2008</a>, <a class="bk_pop" href="#higes.REF.renner.2008.181">Renner et al 2008</a>]</div></li><li class="half_rhythm"><div>Chest imaging revealing pneumatocoeles or bronchiectasis, especially following recurrent pneumonias</div></li><li class="half_rhythm"><div>Spine imaging demonstrating scoliosis in approximately two thirds of individuals older than age 16 years</div></li><li class="half_rhythm"><div>Reduced bone density in approximately 50% of individuals</div></li><li class="half_rhythm"><div>Chiari 1 malformations in approximately 20% of persons, and brain MRI T<sub>2</sub>-weighted focal hyperintensities in approximately 70%</div></li></ul><p><b>Protein analysis.</b> Protein analysis is of limited diagnostic value (see <a href="#higes.Testing_Strategy">Testing Strategy</a>).</p><div id="higes.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p><b>Gene.</b>
<i>STAT3</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> hyper-IgE syndrome (AD-HIES).</p><p><b>Evidence for <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> heterogeneity.</b> A small percentage (&#x0003c;5%) of individuals meeting the clinical criteria for AD-HIES do not have identifiable <i>STAT3</i> pathogenic variants, suggesting the existence of additional, as-yet unidentified loci.</p><div id="higes.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Autosomal Dominant Hyper IgE Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK25507/table/higes.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__higes.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_higes.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_higes.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_higes.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pathogenic Variants Detected</th><th id="hd_h_higes.T.molecular_genetic_testing_used_i_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Detection Frequency by Gene &#x00026; Test Method&#x000a0;<sup>2</sup></th></tr></thead><tbody><tr><td headers="hd_h_higes.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>STAT3</i></td><td headers="hd_h_higes.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_higes.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Missense and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants and small <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions</td><td headers="hd_h_higes.T.molecular_genetic_testing_used_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;95%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_higes.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis of select exons</td><td headers="hd_h_higes.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variants in exons 9-23&#x000a0;<sup>5</sup></td><td headers="hd_h_higes.T.molecular_genetic_testing_used_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="higes.TF.2.1"><p class="no_margin">See <a href="/books/NBK25507/#higes.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#higes.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>2. </dt><dd><div id="higes.TF.2.2"><p class="no_margin">The ability of the test method used to detect a variant that is present in the indicated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a></p></div></dd><dt>3. </dt><dd><div id="higes.TF.2.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="higes.TF.2.4"><p class="no_margin">More than 95% of individuals with findings typical of signal transducer and activator of transcription 3 (STAT3)-deficient hyper IgE syndrome (NIH clinical scores &#x0003e;40 with points coming from both immune and non-immune categories) have a <i>STAT3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> encoding an altered, expressed protein.</p></div></dd><dt>5. </dt><dd><div id="higes.TF.2.5"><p class="no_margin">Exons analyzed may vary by laboratory.</p></div></dd></dl></div></div></div></div></div><div id="higes.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> History and physical examination using the scoring system (including both immune and non-immune categories) outlined in <a href="#higes.Clinical_Diagnosis">Clinical Diagnosis</a> may suggest the diagnosis.</p><ul><li class="half_rhythm"><div>Perform screening blood work to detect elevated serum concentration of IgE and eosinophilia. Other serum immunoglobulins and neutrophil/lymphocyte counts should be in the normal to near-normal range.</div></li><li class="half_rhythm"><div>For clinicians with access to research flow cytometry, greatly diminished Th17 cell number may be indicative of, but not definitive for, HIES.</div></li><li class="half_rhythm"><div>Individuals with a high clinical suspicion should have <i>STAT3</i> sequencing performed.</div></li><li class="half_rhythm"><div>If <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> does not identify a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> analysis may be considered. An <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> that spans exons 22 and 23 has been reported; detected by cDNA analysis, the deletion would have been missed by standard <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> sequencing [<a class="bk_pop" href="#higes.REF.schimke.2010.611">Schimke et al 2010</a>]. However, to date, no pathogenic variants that are out-of-frame, involve the entire <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, or otherwise result in <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> have been reported.</div></li><li class="half_rhythm"><div>Protein analysis is of limited diagnostic value, as all pathogenic variants reported to date are protein positive and each person carries one benign <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>. Phosphorylation of signal transducer and activator of transcription 3 (STAT3) has not been shown to be sensitive for the majority of pathogenic variants.</div></li></ul><p><b>Prenatal diagnosis and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> (PGD)</b> for at-risk pregnancies require prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family.</p></div></div><div id="higes.Clinical_Characteristics"><h2 id="_higes_Clinical_Characteristics_">Clinical Characteristics</h2><div id="higes.Clinical_Description"><h3>Clinical Description</h3><p>Autosomal dominant hyper IgE syndrome (AD-HIES) is a primary immune deficiency syndrome characterized by elevated serum IgE, eczema, and recurrent skin and respiratory tract infections, together with several connective tissue and skeletal abnormalities.</p><p><b>Immunologic characteristics.</b> Individuals with AD-HIES typically manifest in the newborn period with a rash, often diagnosed as eosinophilic pustulosis. The rash evolves into an eczematoid dermatitis that is often driven by staphylococcal infection [<a class="bk_pop" href="#higes.REF.hill.1974.183">Hill &#x00026; Quie 1974</a>, <a class="bk_pop" href="#higes.REF.chamlin.2002.572">Chamlin et al 2002</a>, <a class="bk_pop" href="#higes.REF.eberting.2004.1119">Eberting et al 2004</a>].</p><p>Recurrent staphylococcal boils usually manifest in the first few years of life, and may be &#x0201c;cold,&#x0201d; lacking the cardinal features of inflammation, warmth, redness, and pain.</p><p>Recurrent pneumonias begin as well in the first few years, with the most common bacterial isolates being <i>Staphylococcus aureus, Streptococcus pneumoniae</i>, and <i>Haemophilus influenzae</i>. Abnormal healing of these pneumonias, pneumatocoeles, and bronchiectasis are common complications.</p><p>Staphylococcal infections outside of the lung and skin, such as osteomyelitis or liver abscess, occur much less frequently.</p><p>Mucocutaneous candidiasis affecting the oropharynx, vagina, fingernails, and toenails is common.</p><p>Opportunistic infections may occur, including <i>Pneumocystis jiroveci</i> pneumonia, disseminated histoplasmosis and <i>Cryptococcus</i>, and secondary infection of the pneumatocoeles with molds such as <i>Aspergillus fumigatus</i> or <i>Scedosporium</i> species.</p><p>Decreased central memory T-cell formation may lead to increased incidence of varicella zoster virus (VZV) reactivation and modestly increased levels of circulating Epstein-Barr virus (EBV) [<a class="bk_pop" href="#higes.REF.siegel.2011.806">Siegel et al 2011</a>].</p><p><b>Non-immunologic characteristics.</b> Individuals with AD-HIES have several connective tissue, skeletal, and vascular abnormalities.</p><p>A characteristic facial appearance typically emerges by adolescence characterized by facial asymmetry, deep-set eyes, a broad nose, and prominent skin pores [<a class="bk_pop" href="#higes.REF.borges.1998.303">Borges et al 1998</a>; <a class="bk_pop" href="#higes.REF.grimbacher.1999a.692">Grimbacher et al 1999a</a>]. A high arched palate is common, as are oral mucosal variants including palatal ridges [<a class="bk_pop" href="#higes.REF.domingo.2008.73">Domingo et al 2008</a>]. Failure of primary teeth exfoliation is common; secondary tooth development is normal if the primary teeth are removed.</p><p>Skeletal abnormalities include osteopenia, minimal trauma fractures, and scoliosis. Scoliosis typically develops through childhood and adolescence, and may require surgical correction. Joint hyperextensibilty is common, and adults may have degenerative joint disease. Varying degrees of craniosynostosis can be seen, although surgical correction is rarely required. Skull radiographs often have a beaten copper appearance.</p><p>Brain imaging reveals Chiari 1 malformations in approximately 20% of individuals and focal hyperintensities prominent on T<sub>2</sub>-weighted images in approximately 70% of individuals. The focal hyperintensities are usually localized to the white matter and tend to increase in number with age. Both the Chiari 1 malformations and the hyperintensities are usually asymptomatic [<a class="bk_pop" href="#higes.REF.freeman.2007a.e1121">Freeman et al 2007a</a>].</p><p>Vascular abnormalities including middle-sized arterial tortuosity and aneurysms have been described [<a class="bk_pop" href="#higes.REF.ling.2007.255">Ling et al 2007</a>, <a class="bk_pop" href="#higes.REF.freeman.2011.338">Freeman et al 2011</a>, <a class="bk_pop" href="#higes.REF.chandesris.2012.25">Chandesris et al 2012</a>]. The coronary arteries have been the most completely studied. The combination of tortuosity and dilation is found in approximately 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals; either abnormality is present in approximately 70%. Clinical sequelae have been rare but include myocardial infarction. Cerebral artery aneurysm has also been described and infrequently associated with subarachnoid hemorrhage.</p><p>Symptoms of esophageal dysmotility are present in more than 50% of individuals and manifest as gastrointestinal reflux disease and dysphagia. Upper endoscopy frequently shows eosinophilic esophagitis. Diverticuli can occur at a relatively young age and may be associated with bowel perforation [<a class="bk_pop" href="#higes.REF.stover.2010.1261">Stover et al 2010</a>]. Isolated colonic perforations have also been described.</p><p><b>Major causes of morbidity and mortality.</b> Survival is typically into adulthood, but a shortened life span is typical. Most deaths of individuals with AD-HIES are associated with Gram-negative (<i>Pseudomonas</i>) or filamentous fungal pneumonias (most commonly <i>Aspergillus</i>) infecting damaged lung parenchyma (i.e., pneumatocoeles, bronchiectasis) [<a class="bk_pop" href="#higes.REF.freeman.2007b.1234">Freeman et al 2007b</a>]. Fungi may invade the pulmonary vasculature leading to massive hemoptysis, or may disseminate to multiple organs.</p><p>Complications of arterial aneurysms have included myocardial infarction related to coronary artery aneurysm and subarachnoid hemorrhage related to intracranial aneurysm [<a class="bk_pop" href="#higes.REF.fathi.2011.704">Fathi et al 2011</a>].</p><p>Lymphomas occur at an increased frequency and treatment has been successful with standard chemotherapy. Other malignancies have been reported [<a class="bk_pop" href="#higes.REF.leonard.2004.2521">Leonard et al 2004</a>].</p></div><div id="higes.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No heritable differences in <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> have been identified in individuals with STAT3-deficient hyper IgE syndrome [<a class="bk_pop" href="#higes.REF.heimall.2011.75">Heimall et al 2011</a>]. Pathogenic variants tend to cluster in the DNA-binding and SH2 domains with few <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals having pathogenic variants in the transactivation <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and only one to date in the N-terminal domain [<a class="bk_pop" href="#higes.REF.holland.2007.1608">Holland et al 2007</a>; <a class="bk_pop" href="#higes.REF.minegishi.2007.1058">Minegishi et al 2007</a>; <a class="bk_pop" href="#higes.REF.renner.2008.181">Renner et al 2008</a>; Holland et al, unpublished].</p></div><div id="higes.Penetrance"><h3>Penetrance</h3><p>Intrafamilial variability is minimal and <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> appears to be complete.</p></div><div id="higes.Anticipation"><h3>Anticipation</h3><p>Anticipation has not been observed in STAT3<i>-</i>deficient hyper IgE syndrome.</p><p>Although some reports suggest increasing severity of AD-HIES in successive generations, it is likely that these were instances of milder disease associated with <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for a <i>STAT3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the first generation and more severe disease associated with a <i>STAT3</i> constitutional pathogenic variant in the second and subsequent generations.</p></div><div id="higes.Prevalence"><h3>Prevalence</h3><p>The prevalence of STAT3-deficient hyper IgE syndrome is unknown. The condition is rare. Enrichment in a specific ethnic or racial group has not been reported; gender preference is not seen.</p></div></div><div id="higes.Genetically_Related_Allelic_Disord"><h2 id="_higes_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>No other phenotypes are known to be associated with pathogenic variants in <i>STAT3</i>.</p></div><div id="higes.Differential_Diagnosis"><h2 id="_higes_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Atopic dermatitis.</b> Individuals with severe atopic dermatitis are often suspected of having HIES because of the shared elevation of serum concentration of IgE, and many individuals with atopic dermatitis have recurrent staphylococcal skin infections. However, the other features of AD-HIES are typically not present, and individuals with severe atopic dermatitis often have increased numbers and severity of allergies (e.g., environmental, food that may lead to anaphylaxis) than do individuals with AD-HIES.</p><p><b>Autosomal recessive hyper IgE syndrome (AR-HIES)</b> is a distinct clinical disorder, characterized by elevated serum concentration of IgE, severe eczema, and recurrent skin and lung infections [<a class="bk_pop" href="#higes.REF.renner.2004.93">Renner et al 2004</a>]. It differs from STAT3-deficient hyper IgE syndrome by an increased incidence of neurologic abnormalities, an increased occurrence of viral infections of the skin (e.g., <i>Molluscum contagiosum</i>, warts), and absence of the non-immunologic findings of AD-HIES (e.g., retention of primary teeth) [<a class="bk_pop" href="#higes.REF.renner.2004.93">Renner et al 2004</a>]. Pathogenic variants in <i>DOCK8</i> have now been identified as a cause of AR-HIES.</p><p>Combined immunodeficiency associated with <i>DOCK8</i> pathogenic variants is characterized by eczema, allergies, sinopulmonary infections, and viral skin infections including herpes simplex virus (HSV), varicella-zoster virus (VZV), <i>Molluscum contagiosum</i>, and human papillomavirus (HPV) [<a class="bk_pop" href="#higes.REF.zhang.2009.2046">Zhang et al 2009</a>, <a class="bk_pop" href="#higes.REF.engelhardt.2009.1289">Engelhardt et al 2009</a>]. Affected individuals have increased risk for malignancy; squamous cell carcinomas and lymphoma have been reported. DOCK8 deficiency is frequently associated with lymphopenia, which often progresses with age, and serum IgM levels may be low or undetectable. Eosinophilia and IgE are both variable, but can be extremely elevated.</p><p><b>TYK2 deficiency.</b> A single report of human TYK2 deficiency described moderately high serum concentration of IgE in conjunction with disseminated bacillus Calmette-Gu&#x000e9;rin (BCG) infection and susceptibility to viral and other infections [<a class="bk_pop" href="#higes.REF.minegishi.2006.745">Minegishi et al 2006</a>]. However, subsequent reports of TYK2 deficiency have not been associated with the AR-HIES <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#higes.REF.kilic.2012.1055">Kilic et al 2012</a>].</p><p><a href="/books/n/gene/was/"><b>Wiskott-Aldrich syndrome</b></a>
<b>(WAS)</b> is an <a class="def" href="/books/n/gene/glossary/def-item/x-linked-recessive/">X-linked recessive</a> disorder caused by pathogenic variants in <i>WAS</i>. Similar to HIES, eczema and recurrent infections are present, but WAS has associated thrombocytopenia, a high incidence of autoimmune disease and lymphoma in later childhood and adulthood, and typically more opportunistic infections than seen in HIES. Wiskott-Aldrich syndrome occurs in males, although there have been <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> cases of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> females with skewed X-inactivation resulting in the disease <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#higes.REF.parolini.1998.291">Parolini et al 1998</a>]. Thrombocytopenia with small platelets is a distinguishing feature.</p><p><b>Netherton syndrome</b> is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder caused by pathogenic variants in <i>SPINK5</i>. Netherton syndrome is associated with elevated IgE and rash; however, the rash is typically more ichthyotic in appearance with associated trichorrhexis invaginata (bamboo hair). Frequently an enteropathy is present with failure to thrive.</p><p><b>Omenn syndrome</b> also presents in the newborn period with rash and typically elevated serum IgE. Omenn syndrome is a form of <a href="/books/n/gene/x-scid/">SCID</a> (severe combined immunodeficiency) that can result from pathogenic variants in <i>RAG1</i> or <i>RAG2</i>, <i>DCLRE1C</i> (previously known as Artemis)<i>, IL2RG,</i> and additional combined immunodeficiency genes that allow residual functional activity. Affected infants are usually sicker than those with HIES and have associated lymphadenopathy, hepatosplenomegaly, and opportunistic infections.</p></div><div id="higes.Management"><h2 id="_higes_Management_">Management</h2><div id="higes.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease in an individual diagnosed with hyper IgE syndrome (HIES), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Dermatologic examination</div></li><li class="half_rhythm"><div>Chest imaging</div></li><li class="half_rhythm"><div>Evaluation for scoliosis</div></li><li class="half_rhythm"><div>Dental examination for possible retention of primary teeth</div></li></ul></div><div id="higes.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Currently, there is no cure or targeted treatment for AD-HIES, and the mainstay of therapy is prevention of staphylococcal abscesses and pneumonias with anti-staphylococcal prophylactic antibiotics as well as early aggressive treatment of infections. It is important to institute antibiotic therapy at the earliest sign of infection. Many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals progress from minor to major infection rapidly, and systemic signs of infection may be minimal.</p><ul><li class="half_rhythm"><div>Prophylactic antibiotics targeting <i>Staphylococcus aureus</i> and other pyogenic bacteria are primarily used to prevent the pneumonias and their complications.</div></li><li class="half_rhythm"><div>If structural damage to the lungs (e.g., bronchiectasis and/or pneumatocoeles) occurs, the breadth of antimicrobial coverage is usually extended, as these structural abnormalities become secondarily infected with Gram-negative bacteria (e.g., <i>Pseudomonas</i>) or fungi (e.g., <i>Aspergillus</i>).</div></li><li class="half_rhythm"><div>The combination of prophylactic antimicrobials and aggressive diagnosis and treatment of pneumonias helps to diminish these secondary lung parenchymal abnormalities.</div></li><li class="half_rhythm"><div>Continued use of antifungal agents to control mucocutaneous candidiasis and to prevent pulmonary disease may be necessary.</div></li></ul><p>The skin disease of eczema and recurrent boils is usually well controlled with antiseptic therapies such as diluted bleach baths (~1/2 - 1 cup of bleach per bath tub of water for 15 minutes 3 times weekly) or frequent swimming in a chlorinated pool.</p><ul><li class="half_rhythm"><div>Adequate skin lubrication is needed with frequent bleach baths.</div></li><li class="half_rhythm"><div>Medications such as histamine-1 antagonists to control pruritus are helpful for more significant eczema.</div></li></ul><p>Intravenous or subcutaneous immunoglobulin is used with anecdotal improvement for some individuals, especially those who fail to make protective levels of specific antibodies following vaccination challenge; but prospective, randomized controlled studies of immunoglobulin supplementation have not been performed.</p><p>There is no known treatment or prevention for the non-immunologic characteristics.</p><ul><li class="half_rhythm"><div>As many individuals have osteopenia and minimal trauma fractures, optimizing of calcium and vitamin D intake is prudent. The role of medications such as bisphosphonates for persons with AD-HIES with osteoporosis is largely unexplored.</div></li><li class="half_rhythm"><div>Optimal blood pressure management seems appropriate in light of the arterial abnormalities.</div></li><li class="half_rhythm"><div>Anti-platelet or anticoagulation therapies may be considered for individuals with significant coronary artery aneurysms to prevent myocardial infarction related to clotting with aneurysm.</div></li><li class="half_rhythm"><div>However, any anti-clotting therapies need to be weighed against the risk of hemoptysis, a recognized complication of fungal or bacterial lung disease in individuals with AD-HIES.</div></li></ul><p>The role of hematopoietic cell transplantation (HSCT) in AD-HIES remains unknown. An adult treated for lymphoma with HSCT had improvement of many of the clinical features of HIES and decreasing IgE concentrations, but then died of transplant-related complications [<a class="bk_pop" href="#higes.REF.nester.1998.162">Nester et al 1998</a>]. A young girl with recurrent infections had full engraftment and reduction of serum IgE concentration that rebounded with the cessation of immunosuppression [<a class="bk_pop" href="#higes.REF.gennery.2000.1303">Gennery et al 2000</a>]. Recently, two unrelated <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> teenagers who received HSCT for non-Hodgkin lymphoma were reported. Their immunologic and non-immunologic features, such as osteoporosis and course facial skin, were corrected [<a class="bk_pop" href="#higes.REF.goussetis.2010.392">Goussetis et al 2010</a>].</p></div><div id="higes.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><p>Prophylactic antimicrobials are used to decrease the number of boils and pneumonias. Aberrant healing from pyogenic pneumonias leads to bronchiectasis and pneumatocoeles; therefore, prevention of these pneumonias may lead to better preservation of lung parenchyma and decreased risk of secondary, more difficult to treat pulmonary infections. The role of prophylactic antifungals to prevent pulmonary mold infections is unknown.</p><p>Osteoporosis and minimal trauma fractures are frequent findings. The effect of calcium and vitamin D supplementation is not known.</p></div><div id="higes.Surveillance"><h3>Surveillance</h3><p>Individuals with AD-HIES often lack systemic signs of infection and feel better than one would expect when actively infected; therefore, a high index of suspicion for infection is necessary to permit recognition of pneumonias and institution of antibiotic treatment prior to development of extensive lung damage.</p><ul><li class="half_rhythm"><div>Periodic chest imaging is helpful, especially if pneumonias have occurred, to assess whether structural lesions to the lung (e.g., pneumatocoeles) have formed.</div></li><li class="half_rhythm"><div>Because the microbiology of damaged lung tissue may change over time, it is important to obtain sputum samples intermittently and with acute infections, to direct therapy. Sputum samples should be obtained for microbiology during lung infections.</div></li></ul><p>Scoliosis screening of adolescents is indicated to guide any necessary intervention.</p><p>Dental visits should ensure that primary teeth are removed in a timely fashion if necessary to allow secondary teeth to emerge.</p><p>Periodic laboratory monitoring should be performed for individuals on chronic antimicrobial therapy.</p><p>Individuals with AD-HIES have an increased incidence of lymphoma, which should be considered in the evaluation of lymphadenopathy, masses, or bony lesions.</p></div><div id="higes.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>Molecular genetic testing of at-risk relatives of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a known <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> allows for early diagnosis.</p><p>See <a href="#higes.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="higes.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Cessation of prophylactic antimicrobials is often advised during pregnancy. This may increase the risk of infection and should be taken into consideration. There have been pregnancies without complication, but also instances in which lung disease has worsened after pregnancy, potentially from limited antimicrobial options, delayed radiographic diagnosis, and impaired pulmonary clearance.</p><p>Risks associated with pregnancy should be discussed with <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> females who have pulmonary compromise, severe scoliosis, or other complications of AD-HIES.</p></div><div id="higes.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div><div id="higes.Other"><h3>Other</h3><p>Parents have reported anecdotally that due to the severe eczema of their child, there have been occasions when the health care providers have alerted Child Protective Services reporting that the child is not being kept clean. While skin hygiene is very important, in spite of the best efforts of caregivers, sometimes the skin flares are severe. Questions about parental neglect/abuse have also arisen when a toddler or young child appears with evidence of repeated fractures. Health care providers who are attuned to these possibilities can serve as important advocates for the parents and family.</p></div></div><div id="higes.Genetic_Counseling"><h2 id="_higes_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="higes.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Autosomal dominant hyper IgE syndrome associated with mutation of <i>STAT3</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="higes.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Some individuals diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> hyper IgE syndrome have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> hyper IgE syndrome often has the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The majority of cases reported to date have been caused by <i>de novo</i> pathogenic variants. Simplex cases (i.e., a single occurrence in a family) are common.</div></li><li class="half_rhythm"><div>Individuals with some findings of hyper IgE syndrome have had <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for a <i>STAT3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and have transmitted the variant to offspring [<a class="bk_pop" href="#higes.REF.holland.2007.1608">Holland et al 2007</a>; Hsu and Holland, unpublished data]</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include clinical evaluation and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. Evaluation of parents may determine that one is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> but has escaped previous diagnosis because of a milder phenotypic presentation. Mosaicism may also lead to a milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is low, but not entirely absent. The risk to the sibs of a proband with unaffected parents is higher than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> hyper IgE syndrome has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the status of the proband's parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members may be at risk.</p></div><div id="higes.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#higes.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></b>. When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has clinical evidence of the disorder, it is likely that the proband has a <i>de novo</i> pathogenic variant. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="higes.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>STAT3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for AD-HIES are possible.</p></div></div><div id="higes.Resources"><h2 id="_higes_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Job Research Foundation</b></div><div>459 Columbus Avenue</div><div>Suite 509</div><div>New York NY 10024</div><div><b>Email:</b> info@jobresearchfoundation.org</div><div><a href="https://www.jobresearchfoundation.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.jobresearchfoundation.org</a></div></li><li class="half_rhythm"><div><b>Canadian Immunodeficiencies Patient Organization (CIPO)</b></div><div>362 Concession Road 12</div><div>RR #2</div><div>Hastings Ontario K0L 1Y0</div><div>Canada</div><div><b>Phone:</b> 877-262-2476 (toll-free)</div><div><b>Fax:</b> 866-942-7651 (toll-free)</div><div><b>Email:</b> info@cipo.ca</div><div><a href="http://cipo.ca" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cipo.ca</a></div></li><li class="half_rhythm"><div><b>International Patient Organisation for Primary Immunodeficiencies (IPOPI)</b></div><div>Firside</div><div>Main Road</div><div>Downderry Cornwall PL11 3LE</div><div>United Kingdom</div><div><b>Phone:</b> +44 01503 250 668</div><div><b>Fax:</b> +44 01503 250 668</div><div><b>Email:</b> info@ipopi.org</div><div><a href="http://ipopi.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ipopi.org</a></div></li><li class="half_rhythm"><div><b>Jeffrey Modell Foundation/National Primary Immunodeficiency Resource Center</b></div><div>747 Third Avenue</div><div>New York NY 10017</div><div><b>Phone:</b> 866-463-6474 (toll-free); 212-819-0200</div><div><b>Fax:</b> 212-764-4180</div><div><b>Email:</b> info@jmfworld.org</div><div><a href="http://www.info4pi.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.info4pi.org</a></div></li><li class="half_rhythm"><div><b>European Society for Immunodeficiencies (ESID) Registry</b></div><div>Dr. Gerhard Kindle</div><div>University Medical Center Freiburg Centre of Chronic Immunodeficiency</div><div>Engesserstr. 4</div><div>79106 Freiburg </div><div>Germany</div><div><b>Phone:</b> 49-761-270-34450</div><div><b>Email:</b> esid-registry@uniklinik-freiburg.de</div><div><a href="http://esid.org/Working-Parties/Registry" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ESID Registry</a></div></li><li class="half_rhythm"><div><b>Primary Immunodeficiency Diseases Registry at USIDNET</b></div><div>40 West Chesapeake Avenue</div><div>Suite 308</div><div>Towson MD 21204-4803</div><div><b>Phone:</b> 866-939-7568</div><div><b>Fax:</b> 410-321-0293</div><div><b>Email:</b> contact@usidnet.org</div><div><a href="http://usidnet.org/usidnet-registry/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Primary Immunodeficiency Registry at USIDNET</a></div></li></ul></div><div id="higes.Molecular_Genetics"><h2 id="_higes_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="higes.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Autosomal Dominant Hyper IgE Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK25507/table/higes.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__higes.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_higes.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_higes.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_higes.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_higes.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_higes.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_higes.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_higes.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6774" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>STAT3</i></a></td><td headers="hd_b_higes.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6774" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">17q21<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_higes.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P40763" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Signal transducer and activator of transcription 3</a></td><td headers="hd_b_higes.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/STAT3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">STAT3 database</a><br /><a href="http://structure.bmc.lu.se/idbase/STAT3base/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Mutation registry for Hyper-IgE syndrome (STAT3)</a><br /><a href="https://www.niaid.nih.gov/research/human-hies-mutations-database" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">STAT3base-NIH</a></td><td headers="hd_b_higes.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=STAT3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">STAT3</a></td><td headers="hd_b_higes.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=STAT3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">STAT3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="higes.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="higes.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Autosomal Dominant Hyper IgE Syndrome (<a href="/omim/102582,147060" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK25507/table/higes.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__higes.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/102582" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">102582</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3; STAT3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/147060" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">147060</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPER-IgE RECURRENT INFECTION SYNDROME 1, AUTOSOMAL DOMINANT; HIES1</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>STAT3</i> has 24 exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK25507/#higes.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> There are normal splice variants (see <a href="/books/NBK25507/#higes.molgen.TA">Table A</a>, <b>Gene</b>); there are also rare allelic variants in healthy populations.</p><p><b>Pathogenic variants.</b> Pathogenic variants identified to date include <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, single amino-acid <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions, and splice variants of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 12 resulting in a ten amino-acid in-frame <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> at the start of the DNA binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> [<a class="bk_pop" href="#higes.REF.renner.2008.181">Renner et al 2008</a>; Hsu, unpublished]. There are several hotspot variants in the SH2 and DNA binding domain. Four recurrent variants occur at CpG dinucleotides: c.1144C&#x0003e;T, c.1145G&#x0003e;A, c.1268G&#x0003e;A, and c.1909G&#x0003e;A (see <a class="figpopup" href="/books/NBK25507/table/higes.T.selected_stat3_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="fighigesTselectedstat3pathogenicvarian" rid-ob="figobhigesTselectedstat3pathogenicvarian">Table 3</a>) as well as a recurrent three-base in-frame deletion, c.1387_1389delGTG. The first three account for 64 of 97 identified variants within the DNA binding domain (66%) while the last represents 27 of 55 variants in the SH2 domain (49%). When the <a class="def" href="/books/n/gene/glossary/def-item/recurrent-deletion/">recurrent deletion</a> is included, these five changes account for 61% of pathogenic variants identified in <i>STAT3</i>. Two unrelated individuals were identified with a 3.9-kb deletion spanning exons 22 and 23 resulting in an in-frame deletion of 53 amino acids [<a class="bk_pop" href="#higes.REF.schimke.2010.611">Schimke et al 2010</a>].</p><div id="higes.T.selected_stat3_pathogenic_varian" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>STAT3</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK25507/table/higes.T.selected_stat3_pathogenic_varian/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__higes.T.selected_stat3_pathogenic_varian_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1144C&#x0003e;T&#x000a0;<sup>1</sup></td><td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg382Trp</td><td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_3" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nucleotide/47080104" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_139276<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/21618340" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_644805<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1145G&#x0003e;A&#x000a0;<sup>1</sup></td><td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg382Gln</td></tr><tr><td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1268G&#x0003e;A&#x000a0;<sup>1</sup></td><td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg423Gln</td></tr><tr><td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1387_1389delGTG</td><td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val463del</td></tr><tr><td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1909G&#x0003e;A&#x000a0;<sup>1</sup></td><td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val637Met</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="higes.TF.3.1"><p class="no_margin">Recurrent variants; see <b>Pathogenic variants</b>.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Signal transducer and activator of transcription 3 (STAT3) is a major signal transduction protein involved in many diverse pathways such as wound healing, immunity, cancer, and vascular remodeling.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Expression of a mutated gene product is the rule; thus pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> splice variants, and in-frame insertions/deletions have been associated with AD-HIES. Null alleles have not been detected, consistent with the hypothesis that dominant interfering pathogenic variants are required to produce the condition. Homozygous <i>Stat3</i> knockout mice are embryonic lethal while the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> mice are reported to be phenotypically normal [<a class="bk_pop" href="#higes.REF.takeda.1997.3801">Takeda et al 1997</a>], supporting the <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> mechanism of disease.</p></div><div id="higes.References"><h2 id="_higes_References_">References</h2><div id="higes.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="higes.REF.borges.1998.303">Borges WG, Hensley T, Carey JC, Petrak BA, Hill HR. The face of Job. <span><span class="ref-journal">J Pediatr. </span>1998;<span class="ref-vol">133</span>:303–5.</span> [<a href="/pubmed/9709729" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9709729</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.chamlin.2002.572">Chamlin SL, McCalmont TH, Cunningham BB, Esterly NB, Lai CH, Mallory SB, Mancini AJ, Tamburro J, Frieden IJ. Cutaneous manifestations of hyper-IgE syndrome in infants and children. <span><span class="ref-journal">J Pediatr. </span>2002;<span class="ref-vol">141</span>:572–5.</span> [<a href="/pubmed/12378200" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12378200</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.chandesris.2012.25">Chandesris MO, Azarine A, Ong KT, Taleb S, Boutouyrie P, Mousseaux E, Romain M, Bozec E, Laurent S, Boddaert N, Thumerelle C, Tillie-Leblond I, Hoarau C, Lebranchu Y, Aladjidi N, Tron F, Barlogis V, Body G, Munzer M, Jaussaud R, Suarez F, Cl&#x000e9;ment O, Hermine O, Tedgui A, Lortholary O, Picard C, Mallat Z, Fischer A. Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiency. <span><span class="ref-journal">Circ Cardiovasc Genet. </span>2012;2012;<span class="ref-vol">5</span>:25–34.</span> [<a href="/pubmed/22084479" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22084479</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.domingo.2008.73">Domingo DL, Freeman AF, Davis J, Puck JM, Tianxia W, Holland SM, Hart TC. Novel intraoral phenotypes in hyperimmunoglobulin-E syndrome. <span><span class="ref-journal">Oral Dis. </span>2008;<span class="ref-vol">14</span>:73–81.</span> [<a href="/pubmed/18173452" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18173452</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.eberting.2004.1119">Eberting CL, Davis J, Puck JM, Holland SM, Turner ML. Dermatitis and the newborn rash of hyper-IgE syndrome. <span><span class="ref-journal">Arch Dermatol. </span>2004;<span class="ref-vol">140</span>:1119–25.</span> [<a href="/pubmed/15381553" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15381553</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.engelhardt.2009.1289">Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, Chen A, Kim HS, Lloret MG, Schulze I, Ehl S, Thiel J, Pfeifer D, Veelken H, Niehues T, Siepermann K, Weinspach S, Reisli I, Keles S, Genel F, Kutukculer N, Camcio&#x0011f;lu Y, Somer A, Karakoc-Aydiner E, Barlan I, Gennery A, Metin A, Degerliyurt A, Pietrogrande MC, Yeganeh M, Baz Z, Al-Tamemi S, Klein C, Puck JM, Holland SM, McCabe ER, Grimbacher B, Chatila TA. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2009;<span class="ref-vol">124</span>:1289–302.e4.</span> [<a href="/pmc/articles/PMC2818862/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2818862</span></a>] [<a href="/pubmed/20004785" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20004785</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.farkas.1994">Farkas L. <em>Anthropometry of the Head and Face.</em> 2 ed. New York, NY: Raven Press; 1994:286-301.</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.fathi.2011.704">Fathi AR, Vortmeyer A, Holland SM, Pluta RM. Intracranial aneurysms associated with hyperimmunoglobulinaemia E (Job) syndrome: report of two cases. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2011;<span class="ref-vol">82</span>:704–6.</span> [<a href="/pubmed/20861064" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20861064</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.freeman.2011.338">Freeman AF, Avila EM, Shaw PA, Davis J, Hsu AP, Welch P, Matta JR, Hadigan C, Pettigrew RI, Holland SM, Gharib AM. Coronary artery abnormalities in Hyper-IgE syndrome. <span><span class="ref-journal">J Clin Immunol. </span>2011;<span class="ref-vol">31</span>:338–45.</span> [<a href="/pmc/articles/PMC4091041/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4091041</span></a>] [<a href="/pubmed/21494893" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21494893</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.freeman.2007a.e1121">Freeman AF, Collura-Burke CJ, Patronas NJ, Ilcus LS, Darnell D, Davis J, Puck JM, Holland SM. Brain abnormalities in patients with hyperimmunoglobulin E syndrome. <span><span class="ref-journal">Pediatrics. </span>2007a;<span class="ref-vol">119</span>:e1121–5.</span> [<a href="/pubmed/17438082" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17438082</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.freeman.2007b.1234">Freeman AF, Kleiner DE, Nadiminti H, Davis J, Quezado M, Anderson V, Puck JM, Holland SM. Causes of death in hyper-IgE syndrome. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2007b;<span class="ref-vol">119</span>:1234–40.</span> [<a href="/pubmed/17335882" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17335882</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.gennery.2000.1303">Gennery AR, Flood TJ, Abinun M, Cant AJ. Bone marrow transplantation does not correct the hyper IgE syndrome. <span><span class="ref-journal">Bone Marrow Transplant. </span>2000;<span class="ref-vol">25</span>:1303–5.</span> [<a href="/pubmed/10871737" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10871737</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.goussetis.2010.392">Goussetis E, Peristeri I, Kitra V, Traeger-Synodinos J, Theodosaki M, Psarra K, Kanariou M, Tzortzatou-Stathopoulou F, Petrakou E, Fylaktou I, Kanavakis E, Graphakos S. Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2010;<span class="ref-vol">126</span>:392–4.</span> [<a href="/pubmed/20584545" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20584545</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.grimbacher.1999a.692">Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, Miller JA, O'Connell AC, Puck JM. Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. <span><span class="ref-journal">N Engl J Med. </span>1999a;<span class="ref-vol">340</span>:692–702.</span> [<a href="/pubmed/10053178" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10053178</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.grimbacher.1999b.735">Grimbacher B, Sch&#x000e4;ffer AA, Holland SM, Davis J, Gallin JI, Malech HL, Atkinson TP, Belohradsky BH, Buckley RH, Cossu F, Espa&#x000f1;ol T, Garty BZ, Matamoros N, Myers LA, Nelson RP, Ochs HD, Renner ED, Wellinghausen N, Puck JM. Genetic linkage of hyper-IgE syndrome to chromosome 4. <span><span class="ref-journal">Am J Hum Genet. </span>1999b;<span class="ref-vol">65</span>:735–44.</span> [<a href="/pmc/articles/PMC1377980/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377980</span></a>] [<a href="/pubmed/10441580" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10441580</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.heimall.2011.75">Heimall J, Davis J, Shaw PA, Hsu AP, Gu W, Welch P, Holland SM, Freeman AF. Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES). <span><span class="ref-journal">Clin Immunol. </span>2011;<span class="ref-vol">139</span>:75–84.</span> [<a href="/pmc/articles/PMC3065511/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3065511</span></a>] [<a href="/pubmed/21288777" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21288777</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.hill.1974.183">Hill HR, Quie PG. Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. <span><span class="ref-journal">Lancet. </span>1974;<span class="ref-vol">1</span>:183–7.</span> [<a href="/pubmed/4129875" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4129875</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.holland.2007.1608">Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, Freeman AF, Demidowich A, Davis J, Turner ML, Anderson VL, Darnell DN, Welch PA, Kuhns DB, Frucht DM, Malech HL, Gallin JI, Kobayashi SD, Whitney AR, Voyich JM, Musser JM, Woellner C, Sch&#x000e4;ffer AA, Puck JM, Grimbacher B. STAT3 mutations in the hyper-IgE syndrome. <span><span class="ref-journal">N Engl J Med. </span>2007;<span class="ref-vol">357</span>:1608–19.</span> [<a href="/pubmed/17881745" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17881745</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.kilic.2012.1055">Kilic SS, Hacimustafaoglu M, Boisson-Dupuis S, Kreins AY, Grant AV, Abel L, Casanova JL. A Patient with Tyrosine Kinase 2 Deficiency without Hyper-IgE Syndrome. <span><span class="ref-journal">J Pediatr. </span>2012;<span class="ref-vol">160</span>:1055–7.</span> [<a href="/pmc/articles/PMC3360808/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3360808</span></a>] [<a href="/pubmed/22402565" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22402565</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.leonard.2004.2521">Leonard GD, Posadas E, Herrmann PC, Anderson VL, Jaffe ES, Holland SM, Wilson WH. Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review. <span><span class="ref-journal">Leuk Lymphoma. </span>2004;<span class="ref-vol">45</span>:2521–5.</span> [<a href="/pubmed/15621772" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15621772</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.ling.2007.255">Ling JC, Freeman AF, Gharib AM, Arai AE, Lederman RJ, Rosing DR, Holland SM. Coronary artery aneurysms in patients with hyper IgE recurrent infection syndrome. <span><span class="ref-journal">Clin Immunol. </span>2007;<span class="ref-vol">122</span>:255–8.</span> [<a href="/pmc/articles/PMC6588833/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6588833</span></a>] [<a href="/pubmed/17098478" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17098478</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.ma.2008.1551">Ma CS, Chew GY, Simpson N, Priyadarshi A, Wong M, Grimbacher B, Fulcher DA, Tangye SG, Cook MC. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. <span><span class="ref-journal">J Exp Med. </span>2008;<span class="ref-vol">205</span>:1551–7.</span> [<a href="/pmc/articles/PMC2442632/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2442632</span></a>] [<a href="/pubmed/18591410" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18591410</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.milner.2008.773">Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, Kanno Y, Spalding C, Elloumi HZ, Paulson ML, Davis J, Hsu A, Asher AI, O'Shea J, Holland SM, Paul WE, Douek DC. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. <span><span class="ref-journal">Nature. </span>2008;<span class="ref-vol">452</span>:773–6.</span> [<a href="/pmc/articles/PMC2864108/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2864108</span></a>] [<a href="/pubmed/18337720" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18337720</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.minegishi.2006.745">Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, Takada H, Hara T, Kawamura N, Ariga T, Kaneko H, Kondo N, Tsuge I, Yachie A, Sakiyama Y, Iwata T, Bessho F, Ohishi T, Joh K, Imai K, Kogawa K, Shinohara M, Fujieda M, Wakiguchi H, Pasic S, Abinun M, Ochs HD, Renner ED, Jansson A, Belohradsky BH, Metin A, Shimizu N, Mizutani S, Miyawaki T, Nonoyama S, Karasuyama H. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. <span><span class="ref-journal">Immunity. </span>2006;<span class="ref-vol">25</span>:745–55.</span> [<a href="/pubmed/17088085" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17088085</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.minegishi.2007.1058">Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, Kawamura N, Ariga T, Pasic S, Stojkovic O, Metin A, Karasuyama H. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. <span><span class="ref-journal">Nature. </span>2007;<span class="ref-vol">448</span>:1058–62.</span> [<a href="/pubmed/17676033" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17676033</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.nester.1998.162">Nester TA, Wagnon AH, Reilly WF, Spitzer G, Kjeldsberg CR, Hill HR. Effects of allogeneic peripheral stem cell transplantation in a patient with job syndrome of hyperimmunoglobulinemia E and recurrent infections. <span><span class="ref-journal">Am J Med. </span>1998;<span class="ref-vol">105</span>:162–4.</span> [<a href="/pubmed/9727824" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9727824</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.parolini.1998.291">Parolini O, Ressmann G, Haas OA, Pawlowsky J, Gadner H, Knapp W, Holter W. X-linked Wiskott-Aldrich Syndrome in a Girl. <span><span class="ref-journal">N Engl J Med. </span>1998;<span class="ref-vol">338</span>:291–5.</span> [<a href="/pubmed/9445409" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9445409</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.renner.2004.93">Renner ED, Puck JM, Holland SM, Schmitt M, Weiss M, Frosch M, Bergmann M, Davis J, Belohradsky BH, Grimbacher B. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. <span><span class="ref-journal">J Pediatr. </span>2004;<span class="ref-vol">144</span>:93–9.</span> [<a href="/pubmed/14722525" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14722525</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.renner.2008.181">Renner ED, Rylaarsdam S, Anover-Sombke S, Rack AL, Reichenbach J, Carey JC, Zhu Q, Jansson AF, Barboza J, Schimke LF, Leppert MF, Getz MM, Seger RA, Hill HR, Belohradsky BH, Torgerson TR, Ochs HD. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2008;<span class="ref-vol">122</span>:181–7.</span> [<a href="/pmc/articles/PMC4560358/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4560358</span></a>] [<a href="/pubmed/18602572" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18602572</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.schimke.2010.611">Schimke LF, Sawalle-Belohradsky J, Roesler J, Wollenberg A, Rack A, Borte M, Rieber N, Cremer R, Maass E, Dopfer R, Reichenbach J, Wahn V, Hoenig M, Jansson AF, Roesen-Wolff A, Schaub B, Seger R, Hill HR, Ochs HD, Torgerson TR, Belohradsky BH, Renner ED. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2010;<span class="ref-vol">126</span>:611–7.e1.</span> [<a href="/pubmed/20816194" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20816194</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.siegel.2011.806">Siegel AM, Heimall J, Freeman AF, Hsu AP, Brittain E, Brenchley JM, Douek DC, Fahle GH, Cohen JI, Holland SM, Milner JD. A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. <span><span class="ref-journal">Immunity. </span>2011;<span class="ref-vol">35</span>:806–18.</span> [<a href="/pmc/articles/PMC3228524/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3228524</span></a>] [<a href="/pubmed/22118528" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22118528</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.stover.2010.1261">Stover DG, Freeman AF, Wright PW, Hummell DS, Ness RM. Diverticulitis in a young man with hyper-IgE syndrome. <span><span class="ref-journal">South Med J. </span>2010;<span class="ref-vol">103</span>:1261–3.</span> [<a href="/pmc/articles/PMC3059239/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3059239</span></a>] [<a href="/pubmed/21037522" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21037522</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.takeda.1997.3801">Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T, Akira S. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1997;<span class="ref-vol">94</span>:3801–4.</span> [<a href="/pmc/articles/PMC20521/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC20521</span></a>] [<a href="/pubmed/9108058" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9108058</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.woellner.2010.424">Woellner C, Gertz EM, Sch&#x000e4;ffer AA, Lagos M, Perro M, Glocker EO, Pietrogrande MC, Cossu F, Franco JL, Matamoros N, Pietrucha B, Heropolita&#x00144;ska-Pliszka E, Yeganeh M, Moin M, Espa&#x000f1;ol T, Ehl S, Gennery AR, Abinun M, Breborowicz A, Niehues T, Kilic SS, Junker A, Turvey SE, Plebani A, S&#x000e1;nchez B, Garty BZ, Pignata C, Cancrini C, Litzman J, Sanal O, Baumann U, Bacchetta R, Hsu AP, Davis JN, Hammarstr&#x000f6;m L, Davies EG, Eren E, Arkwright PD, Moilanen JS, Viemann D, Khan S, Mar&#x000f3;di L, Cant AJ, Freeman AF, Puck JM, Holland SM, Grimbacher B. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2010;<span class="ref-vol">125</span>:424–432.e8.</span> [<a href="/pmc/articles/PMC2878129/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2878129</span></a>] [<a href="/pubmed/20159255" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20159255</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="higes.REF.zhang.2009.2046">Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, Matthews HF, Davis J, Turner ML, Uzel G, Holland SM, Su HC. Combined immunodeficiency associated with DOCK8 mutations. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">361</span>:2046–55.</span> [<a href="/pmc/articles/PMC2965730/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2965730</span></a>] [<a href="/pubmed/19776401" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19776401</span></a>]</div></li></ul></div></div><div id="higes.Chapter_Notes"><h2 id="_higes_Chapter_Notes_">Chapter Notes</h2><div id="higes.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>7 June 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 February 2010 (me) Review posted live</div></li><li class="half_rhythm"><div>16 July 2009 (jp) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK25507</span><span class="label">PMID: <a href="/pubmed/20301786" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301786</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/peaf/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/lad-ad/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK25507&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK25507/?report=reader">PubReader</a></li><li><a href="/books/NBK25507/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK25507" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK25507" style="display:none" title="Cite this Page"><div class="bk_tt">Hsu AP, Davis J, Puck JM, et al. Autosomal Dominant Hyper IgE Syndrome. 2010 Feb 23 [Updated 2012 Jun 7]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK25507/pdf/Bookshelf_NBK25507.pdf">PDF version of this page</a> (228K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#higes.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#higes.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#higes.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#higes.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#higes.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#higes.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#higes.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#higes.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#higes.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#higes.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#higes.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6774[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">STAT3</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK25507+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1950646" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1950646" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1950646" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1950646" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/19190525" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes.</a><span class="source">[Pediatr Res. 2009]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Freeman AF, Holland SM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pediatr Res. 2009 May; 65(5 Pt 2):32R-37R. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28197791" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.</a><span class="source">[J Clin Immunol. 2017]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wu J, Chen J, Tian ZQ, Zhang H, Gong RL, Chen TX, Hong L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Clin Immunol. 2017 Feb; 37(2):166-179. Epub 2017 Feb 14.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20477605" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Hyper IgE syndrome: review and future directions.</a><span class="source">[Expert Rev Clin Immunol. 2005]</span><div class="brieflinkpop offscreen_noflow">Hyper IgE syndrome: review and future directions.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Freeman AF, Holland SM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Expert Rev Clin Immunol. 2005 Nov; 1(4):645-51. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/19452285" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Pathogenesis of hyper IgE syndrome.</a><span class="source">[Clin Rev Allergy Immunol. 2010]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Pathogenesis of hyper IgE syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Heimall J, Freeman A, Holland SM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clin Rev Allergy Immunol. 2010 Feb; 38(1):32-8. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/19036057" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hyper IgE (Job's) syndrome: a primary immune deficiency with oral manifestations.</a><span class="source">[Oral Dis. 2009]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hyper IgE (Job's) syndrome: a primary immune deficiency with oral manifestations.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Freeman AF, Domingo DL, Holland SM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Oral Dis. 2009 Jan; 15(1):2-7. Epub 2008 Nov 25.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301786" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301786" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc958d75f66d18aa22912a">Autosomal Dominant Hyper IgE Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Autosomal Dominant Hyper IgE Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:34:05-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE888CBEDFC897510000000005E602A3&amp;ncbi_session=CE888CBEDFC958C1_1510SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK25507%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK25507&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK25507/&amp;ncbi_pagename=Autosomal Dominant Hyper IgE Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE888CBEDFC958C1_1510SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>